ORIGINAL RESEARCH article

Front. Genet.

Sec. Applied Genetic Epidemiology

Volume 16 - 2025 | doi: 10.3389/fgene.2025.1526049

This article is part of the Research TopicAdvanced Genetic and Genomic Methods and Applications for Malaria SurveillanceView all 6 articles

Highly multiplex molecular inversion probe panel in Plasmodium falciparum targeting common SNPs approximates whole genome sequencing assessments for selection and relatedness

Provisionally accepted
Karamoko  NiaréKaramoko Niaré1,2*Rebecca  CrudaleRebecca Crudale1Abebe  FolaAbebe Fola1,2Neeva  Wernsman YoungNeeva Wernsman Young2Victor  AsuaVictor Asua3,4Melissa  ConradMelissa Conrad5Pierre  GashemaPierre Gashema6Anita  GhansahAnita Ghansah7Stan  HangiStan Hangi8Deus  S IshengomaDeus S Ishengoma9Jean-Baptiste  MazaratiJean-Baptiste Mazarati6Ayalew  Jejaw ZelekeAyalew Jejaw Zeleke10Philip  J RosenthalPhilip J Rosenthal5Abdoulaye  A DjimdéAbdoulaye A Djimdé11,12Jonathan  J JulianoJonathan J Juliano13,14,15Jeffrey  A BaileyJeffrey A Bailey1,6*
  • 1Department of Pathology and Laboratory Medicine, Division of Biology and Medicine, Brown University, Providence, United States
  • 2Center for Computational Molecular Biology, Brown University, Providence, Rhode Island, United States
  • 3Institute for Tropical Medicine, Travel Medicine, Human Parasitology, University Hospital and Faculty of Medicine, University of Tübingen, Tübingen, Baden-Württemberg, Germany
  • 4Infectious Diseases Research Collaboration, Kampala, Uganda
  • 5Department of Medicine, University of California, San Francisco, San Francisco, California, United States
  • 6Center for Genomic Biology, Institut d’Enseignement Supérieur de Ruhengeri, Ruhengeri, Rwanda
  • 7Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, Ghana
  • 8Department of Pediatrics, HEAL Africa, Goma, Democratic Republic of Congo
  • 9National Institute for Medical Research, Dar es Salaam, Tanzania; Department of Biochemistry, Kampala International University in Tanzania, Dar es Salaam, Tanzania
  • 10Department of Medical Parasitology, School of Biomedical and Laboratory sciences, University of Gondar, Gondar, Amhara Region, Ethiopia
  • 11Pathogens genomics Diversity Network Africa, Imm. Gwancoura,, Sotuba, Bamako, Mali
  • 12Malaria Research and Training Centre, University of Bamako, Bamako, Mali
  • 13Institute for Global Health and Infectious Diseases, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
  • 14Division of Infectious Diseases, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
  • 15Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States

The final, formatted version of the article will be published soon.

Introduction. The use of next-generation sequencing technologies (NGS) to study parasite populations and their response and evolution to interventions is important to support malaria control and elimination efforts. While whole genome sequencing (WGS) is optimal in terms of assessing the entire genome, it is costly for numerous samples.Targeted approaches selectively enriching for sequence of interest are more affordable and higher throughput but sometimes lack adequate information content for key analyses.. We have developed a highly-multiplexed molecular inversion probe (MIP) panel (IBC2FULL) targeting 4,264 single nucleotide polymorphisms (SNPs) with ≥ 5% minor allele frequency (MAF) in sub-Saharan African regions from publicly available Plasmodium falciparum WGS (n=3,693). We optimized the panel alone and in combination with antimalarial drug resistance MIPs in laboratory P. falciparum strains at different parasitemias, and validated it by sequencing field isolates from Democratic Republic of Congo, Ethiopia, Ghana, Mali, Rwanda, Tanzania and Uganda and evaluating population structure, identity-by-descent (IBD), signals of selection, and complexity of infection (COI) Results. The new panel IBC2FULL consisted of 2,128 MIPs (containing 4,264 common SNPs) spaced by 5.1 -18.4 kb across the entire genome. While these microhaplotypes were developed based on variation from sub-Saharan African WGS, 59.3% (2,529) of SNPs were also common in South-East Asia. The MIPs were balanced to produce more uniform and higher depth coverage at low parasitemia (100 parasites/μL) along with MIPs targeting antimalarial drug resistance genes. Comparing targeted regions extracted from public WGS, IBC2FULL provided higher resolution of local population structure in sub-Saharan Africa than current PCR-based targeted sequencing panels.Sequencing field samples (n=140), IBC2FULL approximated WGS measures of relatedness, population structure, and COI. Interestingly, genome-wide analysis of extended haplotype homozygosity detected the same major peaks of selection as WGS.We also chose a subset of 305 high performing MIPs to create a core panel (IBC2CORE) that produced high-quality data for basic population genomic analysis and accurate estimation of COI.Discussion. IBC2FULL and IBC2CORE provide an improved platform for malaria genomic epidemiology and biology that can approximate WGS for many applications and is deployable for malaria molecular surveillance in resource-limited settings.

Keywords: Malaria, Plasmodium falcifarum, Molecular inversion probe (MIP), Molecular surveillance, genetic epidemiology, targeted sequencing

Received: 11 Nov 2024; Accepted: 14 May 2025.

Copyright: © 2025 Niaré, Crudale, Fola, Wernsman Young, Asua, Conrad, Gashema, Ghansah, Hangi, Ishengoma, Mazarati, Zeleke, Rosenthal, Djimdé, Juliano and Bailey. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Karamoko Niaré, Department of Pathology and Laboratory Medicine, Division of Biology and Medicine, Brown University, Providence, United States
Jeffrey A Bailey, Department of Pathology and Laboratory Medicine, Division of Biology and Medicine, Brown University, Providence, United States

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.